Dolby Laboratories, Inc. DLB Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 87.4%-0.4pp | 87.9%-0.3pp | 88.1%-0.4pp | 88.5%-0.4pp | 88.9%+0.3pp | |
| Operating margin | 18.5%0.0pp | 18.5%-1.2pp | 19.6%-1.3pp | 20.9%+0.4pp | 20.5%-0.2pp | |
| Net margin | 17.9%-0.1pp | 18%-0.9pp | 18.9%-0.7pp | 19.6%+0.2pp | 19.4%-0.5pp | |
| EBITDA margin | 25.2%+0.1pp | 25.2%-1.0pp | 26.1%-1.2pp | 27.4%+0.5pp | 26.8%+0.1pp | |
| Free cash flow margin | 22.1%-6.7pp | 28.8%-3.5pp | 32.3%-0.2pp | 32.5%+2.9pp | 29.6%-0.5pp | |
| Returns | ||||||
| Return on equity | 9.4%0.0pp | 9.4%-0.6pp | 10%-0.5pp | 10.5%+0.2pp | 10.3%-0.5pp | |
| Return on assets | 7.5%-0.1pp | 7.6%-0.5pp | 8%-0.5pp | 8.6%+0.4pp | 8.2%-0.4pp | |
| Return on invested capital | 13.1%+0.2pp | 12.9%-1.0pp | 13.9%+0.5pp | 13.4%+0.6pp | 12.7%-0.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 5.2×0.0× | 5.2×+0.2× | 5×+0.4× | 4.6×+0.5× | 4.2×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3×-0.2× | 3.2×0.0× | 3.2×-0.3× | 3.4×+0.4× | 3×+0.1× | |
| Quick ratio | 2.9×-0.2× | 3.1×0.0× | 3.1×-0.3× | 3.4×+0.4× | 3×+0.1× | |
| Cash ratio | 1.4×-0.2× | 1.6×-0.2× | 1.8×-0.1× | 1.9×+0.3× | 1.6×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -1.8×+0.2× | -2×+0.1× | -2.1×-0.2× | -1.9×+0.1× | -2×-0.4× | |
| Per Share | ||||||
| Book value per share | $27.41+2.0% | $26.87-0.1% | $26.90+0.1% | $26.88+1.8% | $26.40+2.3% | |
| Valuation | ||||||
| Market capitalization | $5.74B-6.2% | $6.12B-11.8% | $6.94B-2.6% | $7.12B-8.0% | $7.74B+3.7% | |
| Enterprise value | $5.11B-5.8% | $5.43B-12.2% | $6.18B-3.5% | $6.41B-8.9% | $7.03B+1.9% | |
| Price / earnings | 23.6×-1.9× | 25.4×-1.8× | 27.2×+0.2× | 27×-3.2× | 30.2×+1.7× | |
| Price / sales | 4.2×-0.4× | 4.6×-0.6× | 5.1×-0.1× | 5.3×-0.6× | 5.9×+0.2× | |
| Price / book | 2.2×-0.2× | 2.4×-0.3× | 2.6×-0.1× | 2.7×-0.3× | 3×0.0× | |
| EV / EBITDA | 14.8×-1.3× | 16.1×-1.4× | 17.5×+0.2× | 17.4×-2.5× | 19.8×+0.2× | |
| EV / sales | 3.7×-0.3× | 4.1×-0.5× | 4.6×-0.2× | 4.8×-0.6× | 5.3×+0.1× | |
| Free cash flow yield | 5.3%-1.1pp | 6.3%0.0pp | 6.3%+0.1pp | 6.1%+1.1pp | 5%-0.2pp | |
| Earnings yield | 4.2%+0.3pp | 3.9%+0.3pp | 3.7%0.0pp | 3.7%+0.4pp | 3.3%-0.2pp | |
| Dividend yield | 2.3%+0.2pp | 2.1%+0.3pp | 1.8%+0.1pp | 1.7%+0.2pp | 1.6%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Dolby Laboratories, Inc.'s profit margins?
- Dolby Laboratories, Inc. (DLB) runs a 87.4% gross margin and a 18.5% operating margin, with a 17.9% net margin.
- Where do Dolby Laboratories, Inc.'s ratios come from?
- Every ratio is computed from Dolby Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.